DE68917407D1 - Bereicherung und Konzentrierung von Proteinen durch Ultrafiltration. - Google Patents

Bereicherung und Konzentrierung von Proteinen durch Ultrafiltration.

Info

Publication number
DE68917407D1
DE68917407D1 DE68917407T DE68917407T DE68917407D1 DE 68917407 D1 DE68917407 D1 DE 68917407D1 DE 68917407 T DE68917407 T DE 68917407T DE 68917407 T DE68917407 T DE 68917407T DE 68917407 D1 DE68917407 D1 DE 68917407D1
Authority
DE
Germany
Prior art keywords
ultrafiltration
enrichment
concentration
proteins
whey
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68917407T
Other languages
English (en)
Other versions
DE68917407T2 (de
Inventor
Christopher Thurman Cordle
Ronald Lewis Thomas
Larry Grant Criswell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE68917407D1 publication Critical patent/DE68917407D1/de
Publication of DE68917407T2 publication Critical patent/DE68917407T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1425—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of whey, e.g. treatment of the UF permeate
DE68917407T 1988-10-12 1989-10-10 Bereicherung und Konzentrierung von Proteinen durch Ultrafiltration. Expired - Fee Related DE68917407T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/256,813 US4897465A (en) 1988-10-12 1988-10-12 Enrichment and concentration of proteins by ultrafiltration

Publications (2)

Publication Number Publication Date
DE68917407D1 true DE68917407D1 (de) 1994-09-15
DE68917407T2 DE68917407T2 (de) 1995-02-02

Family

ID=22973692

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68917407T Expired - Fee Related DE68917407T2 (de) 1988-10-12 1989-10-10 Bereicherung und Konzentrierung von Proteinen durch Ultrafiltration.

Country Status (13)

Country Link
US (1) US4897465A (de)
EP (1) EP0363896B1 (de)
JP (1) JPH02218691A (de)
KR (1) KR900005998A (de)
AT (1) ATE109792T1 (de)
AU (1) AU624633B2 (de)
CA (1) CA1330050C (de)
DE (1) DE68917407T2 (de)
ES (1) ES2061873T3 (de)
IE (1) IE64919B1 (de)
IL (1) IL91781A (de)
MX (1) MX163729B (de)
NZ (1) NZ230993A (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729031D0 (en) * 1987-12-11 1988-01-27 Express Foods Group Ltd Isolation of immunoglobulin rich fraction from whey
US5030720A (en) * 1988-09-01 1991-07-09 Merck & Co., Inc. Pres2+S hepatitis B vaccine derived from plasma
US5130237A (en) * 1989-06-19 1992-07-14 Clemson University Substrate conversion with an enzyme immobilized on an ultrafiltration membrane
DE4026365A1 (de) * 1990-08-21 1992-02-27 Biotest Pharma Gmbh Sterilfiltrierte kolostralmilch
US5270450A (en) * 1991-02-28 1993-12-14 Abbott Laboratories Soy protein isolates
IE914558A1 (en) * 1991-02-28 1992-09-09 Abbott Lab Isolation of proteins by ultrafiltration
CH687055A5 (de) * 1993-12-03 1996-09-13 Bucher Guyer Ag Masch Verfahren und Vorrichtung zum Eindicken von Fest/Fluessig-Gemischen mittels Membrantechnologie.
US5310877A (en) * 1993-04-08 1994-05-10 E. I. Du Pont De Nemours And Company Method for separating serum albumin and gamma globulin
US5344565A (en) * 1993-07-26 1994-09-06 Pall Corporation Method of treating a clogged porous medium
NL9301653A (nl) * 1993-09-24 1995-04-18 X Flow Bv Werkwijze voor het verwijderen van troebelheid veroorzakende bestanddelen uit een vloeistof met behulp van microfiltratie.
US5468844A (en) * 1994-01-07 1995-11-21 Protose Technologies Inc. Process for the membrane-filtering of protein solutions
US5707678A (en) * 1995-04-12 1998-01-13 Galagen Inc. Method for microfiltration of milk or colostral whey
US5654025A (en) * 1995-10-30 1997-08-05 Raghunath; Bala Ultrafiltration of cooled milk
US6268487B1 (en) 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
CA2197515A1 (en) * 1996-07-15 1998-01-16 Reyad Mahmoud Methods of treating milk products
US6478969B2 (en) 1996-09-06 2002-11-12 Pall Corporation Shear separation method and system
AU7701398A (en) 1997-05-30 1998-12-30 Bion, Inc. Large-scale isolation and purification of hif
TW409035B (en) 1997-06-04 2000-10-21 Gist Brocades Bv Starch-based enzyme granulates
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
BR9909584A (pt) * 1998-04-14 2000-12-19 Dsm Nv Filtração por membrana
US6313273B1 (en) * 1999-08-25 2001-11-06 Abbott Laboratories Soy proteins and methods for their production
JP2003532681A (ja) * 2000-05-05 2003-11-05 ジーティーシー バイオセラピューティックス インコーポレイテッド 遺伝子導入により産生されたデコリン
US20040219281A1 (en) * 2000-11-21 2004-11-04 Cargill, Incorporated Modified oilseed material
IL156017A0 (en) 2000-11-21 2003-12-23 Cargill Inc Modified oilseed material
US7429399B2 (en) * 2001-06-18 2008-09-30 Solae, Llc Modified oilseed material
US6630195B1 (en) 2000-11-21 2003-10-07 Cargill, Incorporated Process for producing oilseed protein products
US6875459B2 (en) * 2001-09-10 2005-04-05 Henry B. Kopf Method and apparatus for separation of milk, colostrum, and whey
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
MY150740A (en) * 2002-10-24 2014-02-28 Abbvie Biotechnology Ltd Low dose methods for treating disorders in which tnf? activity is detrimental
CN1729298A (zh) * 2002-11-27 2006-02-01 Gtc生物治疗学公司 在乳汁中稳定生成的修饰抗体及其制备方法
US7354616B2 (en) * 2003-11-25 2008-04-08 Solae, Llc Modified oilseed material with a high gel strength
US7282571B2 (en) * 2004-02-03 2007-10-16 Cytoskeleton Inc. Methods for stabilizing proteins
US20050220978A1 (en) * 2004-03-31 2005-10-06 Cargill, Incorporated Dispersible protein composition
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
US20080019905A9 (en) * 2005-02-18 2008-01-24 Strome Scott E Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
WO2007048077A2 (en) * 2005-10-21 2007-04-26 Gtc Biotherapeutics, Inc. Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use
MX2009010361A (es) 2007-03-29 2009-10-16 Abbott Lab Anticuerpos il-12 anti-humanos cristalinos.
EP2279003A4 (de) * 2008-05-01 2013-04-03 Gtc Biotherapeutics Inc Anti-cd137-antikörper als mittel zur behandlung von entzündlichen erkrankungen
RU2011126338A (ru) * 2008-11-28 2013-01-10 Эбботт Лэборетриз Стабильные композиции антител и способы их стабилизации
TWI445714B (zh) 2009-05-27 2014-07-21 Baxter Int 產製用於皮下使用之高濃度免疫球蛋白製備物之方法
CN102574059B (zh) * 2009-08-10 2014-12-10 丹尼斯科美国公司 用于蛋白质回收的基于交叉流动膜过滤的方法
US9809630B2 (en) 2012-05-09 2017-11-07 The University Of Akron Enzyme-based protein separation and enrichment from soy meal, wheat meal, and other protein-rich materials derived from plant seeds, fruits and other biomass
MX369465B (es) 2012-08-22 2019-11-08 Kraft Foods Group Brands Llc Queso procesado con componentes lácteos cultivados y método de fabricación.
EP3636657A1 (de) * 2018-10-08 2020-04-15 Ablynx N.V. Chromatographiefreies antikörperreinigungsverfahren

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3431201A (en) * 1967-08-29 1969-03-04 Atomic Energy Commission Hyperfiltration process having ion exchange pretreatment
ES369944A1 (es) * 1969-07-26 1971-12-01 Inst Llorente S A Procedimiento para separar proteinas en estado de gran pu- reza a partir de mezclas complejas proteicas.
US3977967A (en) * 1973-05-10 1976-08-31 Union Carbide Corporation Ultrafiltration apparatus and process for the treatment of liquids
NL7603369A (en) * 1976-03-31 1977-10-04 Stichting Bedrijven Van Het Selective removal of inorganic ions from aq. protein concentrates - by ultrafiltration and diafiltration at controlled pH
FR2459619B1 (fr) * 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
DE3432718C1 (de) * 1984-09-06 1986-05-22 Biotest Pharma GmbH, 6000 Frankfurt Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
FR2605322B1 (fr) * 1986-10-20 1989-04-28 Applic Tech Nles Procede de separation de certaines proteines du lactoserum ou du lait.

Also Published As

Publication number Publication date
EP0363896A2 (de) 1990-04-18
IE64919B1 (en) 1995-09-20
EP0363896A3 (de) 1991-08-14
IL91781A (en) 1994-06-24
KR900005998A (ko) 1990-05-07
NZ230993A (en) 1991-11-26
DE68917407T2 (de) 1995-02-02
MX163729B (es) 1992-06-17
AU4257089A (en) 1990-04-26
CA1330050C (en) 1994-06-07
EP0363896B1 (de) 1994-08-10
ES2061873T3 (es) 1994-12-16
IL91781A0 (en) 1990-06-10
US4897465A (en) 1990-01-30
ATE109792T1 (de) 1994-08-15
AU624633B2 (en) 1992-06-18
IE893057L (en) 1990-04-12
JPH02218691A (ja) 1990-08-31

Similar Documents

Publication Publication Date Title
DE68917407D1 (de) Bereicherung und Konzentrierung von Proteinen durch Ultrafiltration.
DK38892A (da) Proteinpraeparat, monoklonalt antistof fremstillet dermed, fremgangsmaade og middel til detektering, dna-sekvens og extrachromosomalt element indeholdende en saadan dna-sekvens
FI854187L (fi) Immunoanalyser foer denaturerade proteinanalyser, saerskilt hb alc, samt antikroppar anvaendbara i dessa.
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
GB8723651D0 (en) Process for containing concentrates
ATE68826T1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
SE8602877L (sv) Extraktionsforfarande for mjolkproteiner, produkter, anvendning av forfarandet och farmaceutiska kompositioner
ATE84193T1 (de) Isolierung einer immunoglobulinreichen molkefraktion.
EP0299741A3 (de) Verfahren und Vorrichtung zur Sequenzierung von Proteinen oder Peptiden
FR2660757B1 (fr) Procede d'identification ou de dosage de proteines et applications.
DE3854550T2 (de) HIV-Peptide und Methoden für den Nachweis von HIV.
ATE50458T1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
ATE98377T1 (de) Verfahren zur selektiven immunologischen bestimmung von intaktem prokollagen peptid (typ iii) und prokollagen (typ iii) in koerperfluessigkeiten und mittel zu dessen durchfuehrung.
DE3273606D1 (en) Process for the purification or concentration of biologically active proteins, and appropriate means therefor
ATE82471T1 (de) Verfahren zur abtrennung bestimmter proteine aus molke.
SE8802176D0 (sv) Fusion protein and its use
DE68917520D1 (de) Verfahren und Systeme zur Herstellung von HIV-Antigenen.
ATE90569T1 (de) Praeparat mit antikoerperaktivitaet und breitem wirkungsspektrum, daraus bestehende oder diese enthaltende mittel und deren verwendung zur behandlung von bakteriell oder toxin-bedingten erkrankungen und zur bekaempfung von protozoen.
IT8421612A0 (it) Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.
SE8305667D0 (sv) Adenocarcinoma related new antigenic determinants and antibodies specific thereto, processes for their preparation and reagent systems pertaining to them
ATE60247T1 (de) Modifizierte anorganische filtermembran zur proteintrennung.
IT1080780B (it) Immunosiero contenente degli anticorpi specifici di proteine di un latte e procedimento di controllo del latte e dei formaggi
ATA166890A (de) Rekombinantes dna-molekül für allergene des erlenpollens, damit hergestellte proteine bzw. polypeptide, sowie deren anwendung
HUT49151A (en) Process for production of biotinilated proteins

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee